Este folleto presenta los datos sobre la mortalidad por ENT y la prevalencia de factores de riesgo de las ENT, para los países en la región de las Américas. Su contenido está enfocado en la agenda 5 x 5 de ENT que incluye las principals ENT (enfermedades cardiovasculares, cáncer, diabetes y enf...ermedades respiratorias crónicas) y la salud mental (suicidio); así como los principales factores de riesgo de ENT (consumo de tabaco, uso no civo del alcohol, dieta p oco s aludable, ac tividad física insuficiente) junto con la contaminación del aire. Incluye información sobre el número y porcentaje de muertes, tasas de mortalidad estandarizadas por edad, muerte prematura por ENT y la prevalencia de los principales factores de riesgo de las ENT.
more
Análisis de las inequidades en salud reproductiva, materna, neonatal, de la niñez y de la adolescencia en América Latina y el Caribe para guiar la formulación de políticas
This document aims to provide concrete, pragmatic guidance for how TB modelling and related technical assistance is undertaken to support country decision-making. The target audience for this document are the participants and stakeholders in country-level TB modelling efforts, including the individu...als who build and apply models; policy-makers, technical experts and other members of the TB community; international funding and technical partners; and individuals and organizations engaged in supporting TB policy-making.
more
Amphetamine-type stimulants, new psychoactive substances
-4-
World Drug Report 2017
Accessed: 14.03.2019
Policy brief based on the 2007 Rwanda Service Provision Assessment (RSPA) survey. The 2007 RSPA survey describes how the formal health sector in Rwanda provides services for family planning, maternal health, child health, malaria, HIV/AIDS, and other communicable diseases.
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half in the countries in which the Global Fund invests.
The Kenya Essential Medicines List 2019 is an indispensable guide to the medicines recommended for the management of common conditions in Kenya. It is primarily directed at health care providers and medicines supply managers in the public and non-public health sectors. It should be used together wit...h the current versions of updated national clinical guidelines for those conditions for which such guidelines exist
more